Table 1.

Selected Characteristics of Participants (N = 100)

Characteristic	n	%
Female	46	46%
Age
8-<12 y	34	34%
12-<16 y	56	56%
16-<19 y	10	10%
Race/ethnicity
White/others	17	17%
African-American	54	54%
Hispanic	29	29%
Spanish primary language
No	87	87%
Yes	13	13%
Primary caregiver
Biological parent	41	41%
Relative	24	24%
Other adult	34	34%
Shelter/home	1	1%
Education level of primary caregiver
Grade 1-11	25	25%
High school graduate	29	29%
Some college/technical school	27	27%
College graduate or higher	10	10%
Other/not reported	9	9%
CD4 percent
≤15%	8	8%
15-25%	26	27%
≥25%	62	65%
Missing	4	—
HIV viral load (copies/mL)
≤400 copies	57	59%
400-10,000 copies	22	23%
10,000-100,000 copies	13	13%
>100,000 copies	5	5%
Missing	3	—
CDC class C
No	65	65%
Yes	35	35%
On PI at adherence visit
No	22	22%
Yes	78	78%
On HAART at adherence visit
No	8	8%
Yes	92	92%
Maximum daily drug dosage
Once a day	4	4%
Twice a day	94	94%
Three times a day	2	2%
Prescribed number of pills per day
1-<5	21	21%
5-<10	38	38%
10-<15	25	25%
≥15	16	16%
Regimen with drug not in pill form
No	81	81%
Yes	19	19%
Responsibility for medication (caregiver-reported)
Caregiver fully responsible	53	54%
Child and caregiver shared responsibility	36	36%
Child fully responsible	10	10%
Missing	1	—
Had recent life stress
No	53	55%
Yes	43	45%
Missing	4	—
School attendance limited by illness
No	85	89%
Yes	10	11%
Missing	5	—

CDC, center for disease control and prevention; PI, protease inhibitor; HAART, highly active antiretroviral therapy.